IIZUKA, Toshiaki
Publications 2010-
"Promoting Innovation in Small Markets: Evidence from the Market for Rare and Intractable Diseases" (with Gyo Uchida), Journal of Health Economics, 2017, 54: 56-65.
"Patient Cost Sharing and Medical Expenditures for the Elderly" (with K. Fukushima, S. Mizuoka, and S. Yamamoto), Journal of Health Economics, 2016, 45: 115-130.
"The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program," (with Y. Watanabe), Health Economics, 2016, 25(11): 1433–1447.
"Cartel sustainability in retail markets: Evidence from a health service sector" (with Ujo Goto), International Journal of Industrial Organization, 2016, 49:36-58.
"Durable Goods Price Cycles: Theory and Evidence from the Textbook Market" (with Rick Bond), Economic Inquiry, 2014, 52(2):518-538
"Markets with Physician Dispensing," Encyclopedia of Health Economics, Tony Culyer ed., 2014, Elsevier.
"Does Higher Malpractice Pressure Deter Medical Errors?" Journal of Law and Economics, 2013, 56(1): 161-188
"Physician Agency and Adoption of Generic Pharmaceuticals," American Economic Review, 2012, 102(6): 2826-2858
"The Japanese Generic Drug Market: Will it finally Take-off?" (with K. Kubo), Health Economics, Policy, and Law, 6(3), 2011, pp. 369-389

"Generic Entry in a Regulated Pharmaceutical Market," Japanese Economic Review, 60(1), 2009, pp. 63-81
"The Economics of Pharmaceutical Pricing and Physician Prescribing in Japan," in Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific, K. Eggleston, ed., Brooking Press, 2009
"Experts’ Agency Problems: Evidence from the Prescription Drug Market in Japan," RAND Journal of Economics, 38(3), 2007, pp. 844-862
"Direct to Consumer Advertising and Prescription Choice," (with Ginger Zhe Jin), Journal of Industrial Economics, 55(4), 2007, pp. 771-771
"An Empirical Analysis of Planned Obsolescence," Journal of Economics and Management Strategy, 16(1), 2007, pp. 191-226
"The Effect of Prescription Drug Advertising on Doctor Visits," (with Ginger Zhe Jin), Journal of Economics and Management Strategy, 14(3), 2005, pp.701-727
"What Explains the Use of Direct to Consumer Advertising of Prescription Drugs?" Journal of Industrial Economics, 52(3), 2004, pp. 349-379